IBDEI02O ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3058,1,8,0)
 ;;=8^Anemia in Chr Kidney Disease
 ;;^UTILITY(U,$J,358.3,3058,2)
 ;;=^321977
 ;;^UTILITY(U,$J,358.3,3059,0)
 ;;=285.22^^29^255^5
 ;;^UTILITY(U,$J,358.3,3059,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3059,1,1,0)
 ;;=1^285.22
 ;;^UTILITY(U,$J,358.3,3059,1,8,0)
 ;;=8^Anemia In Neoplastic Disease
 ;;^UTILITY(U,$J,358.3,3059,2)
 ;;=^321978
 ;;^UTILITY(U,$J,358.3,3060,0)
 ;;=285.29^^29^255^6
 ;;^UTILITY(U,$J,358.3,3060,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3060,1,1,0)
 ;;=1^285.29
 ;;^UTILITY(U,$J,358.3,3060,1,8,0)
 ;;=8^Anemia Oth Chronic Illness
 ;;^UTILITY(U,$J,358.3,3060,2)
 ;;=^321979
 ;;^UTILITY(U,$J,358.3,3061,0)
 ;;=285.1^^29^255^1
 ;;^UTILITY(U,$J,358.3,3061,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3061,1,1,0)
 ;;=1^285.1
 ;;^UTILITY(U,$J,358.3,3061,1,8,0)
 ;;=8^Ac Posthemorrhag Anemia
 ;;^UTILITY(U,$J,358.3,3061,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,3062,0)
 ;;=284.2^^29^255^30
 ;;^UTILITY(U,$J,358.3,3062,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3062,1,1,0)
 ;;=1^284.2
 ;;^UTILITY(U,$J,358.3,3062,1,8,0)
 ;;=8^Myelophthisic Anemia
 ;;^UTILITY(U,$J,358.3,3062,2)
 ;;=^334037
 ;;^UTILITY(U,$J,358.3,3063,0)
 ;;=281.9^^29^255^14
 ;;^UTILITY(U,$J,358.3,3063,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3063,1,1,0)
 ;;=1^281.9
 ;;^UTILITY(U,$J,358.3,3063,1,8,0)
 ;;=8^Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,3063,2)
 ;;=^123801
 ;;^UTILITY(U,$J,358.3,3064,0)
 ;;=282.41^^29^255^46
 ;;^UTILITY(U,$J,358.3,3064,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3064,1,1,0)
 ;;=1^282.41
 ;;^UTILITY(U,$J,358.3,3064,1,8,0)
 ;;=8^Sickle Cell Thalassemia w/o crisis
 ;;^UTILITY(U,$J,358.3,3064,2)
 ;;=^329908
 ;;^UTILITY(U,$J,358.3,3065,0)
 ;;=284.11^^29^255^10
 ;;^UTILITY(U,$J,358.3,3065,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3065,1,1,0)
 ;;=1^284.11
 ;;^UTILITY(U,$J,358.3,3065,1,8,0)
 ;;=8^Antineoplastic Chemo Indcd Panycyt
 ;;^UTILITY(U,$J,358.3,3065,2)
 ;;=^340499
 ;;^UTILITY(U,$J,358.3,3066,0)
 ;;=284.12^^29^255^33
 ;;^UTILITY(U,$J,358.3,3066,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3066,1,1,0)
 ;;=1^284.12
 ;;^UTILITY(U,$J,358.3,3066,1,8,0)
 ;;=8^Oth Drug Indcd Pancytopenia
 ;;^UTILITY(U,$J,358.3,3066,2)
 ;;=^340500
 ;;^UTILITY(U,$J,358.3,3067,0)
 ;;=284.19^^29^255^36
 ;;^UTILITY(U,$J,358.3,3067,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3067,1,1,0)
 ;;=1^284.19
 ;;^UTILITY(U,$J,358.3,3067,1,8,0)
 ;;=8^Oth Pancytopenia
 ;;^UTILITY(U,$J,358.3,3067,2)
 ;;=^340501
 ;;^UTILITY(U,$J,358.3,3068,0)
 ;;=281.1^^29^255^43
 ;;^UTILITY(U,$J,358.3,3068,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3068,1,1,0)
 ;;=1^281.1
 ;;^UTILITY(U,$J,358.3,3068,1,8,0)
 ;;=8^Oth Vit B12 Deficiency Anemia
 ;;^UTILITY(U,$J,358.3,3068,2)
 ;;=^267974
 ;;^UTILITY(U,$J,358.3,3069,0)
 ;;=281.2^^29^255^16
 ;;^UTILITY(U,$J,358.3,3069,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3069,1,1,0)
 ;;=1^281.2
 ;;^UTILITY(U,$J,358.3,3069,1,8,0)
 ;;=8^Folate-deficiency Anemia
 ;;^UTILITY(U,$J,358.3,3069,2)
 ;;=^259686
 ;;^UTILITY(U,$J,358.3,3070,0)
 ;;=281.3^^29^255^41
 ;;^UTILITY(U,$J,358.3,3070,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3070,1,1,0)
 ;;=1^281.3
 ;;^UTILITY(U,$J,358.3,3070,1,8,0)
 ;;=8^Oth Spec Megaloblastic Anemia NEC
 ;;^UTILITY(U,$J,358.3,3070,2)
 ;;=^88100
 ;;^UTILITY(U,$J,358.3,3071,0)
 ;;=281.4^^29^255^45
 ;;^UTILITY(U,$J,358.3,3071,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3071,1,1,0)
 ;;=1^281.4
 ;;^UTILITY(U,$J,358.3,3071,1,8,0)
 ;;=8^Protein-deficiency Anemia
 ;;^UTILITY(U,$J,358.3,3071,2)
 ;;=^267975
 ;;^UTILITY(U,$J,358.3,3072,0)
 ;;=282.0^^29^255^25
 ;;^UTILITY(U,$J,358.3,3072,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3072,1,1,0)
 ;;=1^282.0
 ;;^UTILITY(U,$J,358.3,3072,1,8,0)
 ;;=8^Hereditary Spherocytosis
 ;;^UTILITY(U,$J,358.3,3072,2)
 ;;=^113079
 ;;^UTILITY(U,$J,358.3,3073,0)
 ;;=282.1^^29^255^23
 ;;^UTILITY(U,$J,358.3,3073,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3073,1,1,0)
 ;;=1^282.1
 ;;^UTILITY(U,$J,358.3,3073,1,8,0)
 ;;=8^Hereditary Elliptocytosis
 ;;^UTILITY(U,$J,358.3,3073,2)
 ;;=^39378
 ;;^UTILITY(U,$J,358.3,3074,0)
 ;;=282.2^^29^255^8
 ;;^UTILITY(U,$J,358.3,3074,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3074,1,1,0)
 ;;=1^282.2
 ;;^UTILITY(U,$J,358.3,3074,1,8,0)
 ;;=8^Anemias d/t Diso of Glutathione
 ;;^UTILITY(U,$J,358.3,3074,2)
 ;;=^7225
 ;;^UTILITY(U,$J,358.3,3075,0)
 ;;=282.3^^29^255^35
 ;;^UTILITY(U,$J,358.3,3075,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3075,1,1,0)
 ;;=1^282.3
 ;;^UTILITY(U,$J,358.3,3075,1,8,0)
 ;;=8^Oth Hemolytic Anemias d/t Enzyme
 ;;^UTILITY(U,$J,358.3,3075,2)
 ;;=^267980
 ;;^UTILITY(U,$J,358.3,3076,0)
 ;;=282.40^^29^255^54
 ;;^UTILITY(U,$J,358.3,3076,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3076,1,1,0)
 ;;=1^282.40
 ;;^UTILITY(U,$J,358.3,3076,1,8,0)
 ;;=8^Thalassemia,Unspec
 ;;^UTILITY(U,$J,358.3,3076,2)
 ;;=^340606
 ;;^UTILITY(U,$J,358.3,3077,0)
 ;;=282.42^^29^255^48
 ;;^UTILITY(U,$J,358.3,3077,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3077,1,1,0)
 ;;=1^282.42
 ;;^UTILITY(U,$J,358.3,3077,1,8,0)
 ;;=8^Sickle-cell Thalassemia w/ Crisis
 ;;^UTILITY(U,$J,358.3,3077,2)
 ;;=^329909
 ;;^UTILITY(U,$J,358.3,3078,0)
 ;;=282.43^^29^255^4
 ;;^UTILITY(U,$J,358.3,3078,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3078,1,1,0)
 ;;=1^282.43
 ;;^UTILITY(U,$J,358.3,3078,1,8,0)
 ;;=8^Alpha Thalessemia
 ;;^UTILITY(U,$J,358.3,3078,2)
 ;;=^340494
 ;;^UTILITY(U,$J,358.3,3079,0)
 ;;=282.44^^29^255^12
 ;;^UTILITY(U,$J,358.3,3079,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3079,1,1,0)
 ;;=1^282.44
 ;;^UTILITY(U,$J,358.3,3079,1,8,0)
 ;;=8^Beta Thalassemia
 ;;^UTILITY(U,$J,358.3,3079,2)
 ;;=^340495
 ;;^UTILITY(U,$J,358.3,3080,0)
 ;;=282.45^^29^255^15
 ;;^UTILITY(U,$J,358.3,3080,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3080,1,1,0)
 ;;=1^282.45
 ;;^UTILITY(U,$J,358.3,3080,1,8,0)
 ;;=8^Delta-beta Thalassemia
 ;;^UTILITY(U,$J,358.3,3080,2)
 ;;=^340496
 ;;^UTILITY(U,$J,358.3,3081,0)
 ;;=282.46^^29^255^53
 ;;^UTILITY(U,$J,358.3,3081,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3081,1,1,0)
 ;;=1^282.46
 ;;^UTILITY(U,$J,358.3,3081,1,8,0)
 ;;=8^Thalassemia Minor
 ;;^UTILITY(U,$J,358.3,3081,2)
 ;;=^340497
 ;;^UTILITY(U,$J,358.3,3082,0)
 ;;=282.47^^29^255^19
 ;;^UTILITY(U,$J,358.3,3082,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3082,1,1,0)
 ;;=1^282.47
 ;;^UTILITY(U,$J,358.3,3082,1,8,0)
 ;;=8^Hemoglobin E-beta Thalassemia
 ;;^UTILITY(U,$J,358.3,3082,2)
 ;;=^340498
 ;;^UTILITY(U,$J,358.3,3083,0)
 ;;=282.49^^29^255^42
 ;;^UTILITY(U,$J,358.3,3083,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3083,1,1,0)
 ;;=1^282.49
 ;;^UTILITY(U,$J,358.3,3083,1,8,0)
 ;;=8^Oth Thalassemia
 ;;^UTILITY(U,$J,358.3,3083,2)
 ;;=^329910
 ;;^UTILITY(U,$J,358.3,3084,0)
 ;;=282.5^^29^255^49
 ;;^UTILITY(U,$J,358.3,3084,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3084,1,1,0)
 ;;=1^282.5
 ;;^UTILITY(U,$J,358.3,3084,1,8,0)
 ;;=8^Sickle-cell Trait
 ;;^UTILITY(U,$J,358.3,3084,2)
 ;;=^110419
 ;;^UTILITY(U,$J,358.3,3085,0)
 ;;=282.60^^29^255^47
 ;;^UTILITY(U,$J,358.3,3085,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3085,1,1,0)
 ;;=1^282.60
 ;;^UTILITY(U,$J,358.3,3085,1,8,0)
 ;;=8^Sickle-cell Disease Unspec
 ;;^UTILITY(U,$J,358.3,3085,2)
 ;;=^330077
 ;;^UTILITY(U,$J,358.3,3086,0)
 ;;=282.62^^29^255^17
 ;;^UTILITY(U,$J,358.3,3086,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3086,1,1,0)
 ;;=1^282.62
 ;;^UTILITY(U,$J,358.3,3086,1,8,0)
 ;;=8^Hb-SS Disease w/ Crisis
 ;;^UTILITY(U,$J,358.3,3086,2)
 ;;=^330079
 ;;^UTILITY(U,$J,358.3,3087,0)
 ;;=282.61^^29^255^18
 ;;^UTILITY(U,$J,358.3,3087,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3087,1,1,0)
 ;;=1^282.61
 ;;^UTILITY(U,$J,358.3,3087,1,8,0)
 ;;=8^Hb-SS Disease w/o Crisis
 ;;^UTILITY(U,$J,358.3,3087,2)
 ;;=^330078
 ;;^UTILITY(U,$J,358.3,3088,0)
 ;;=282.63^^29^255^51
 ;;^UTILITY(U,$J,358.3,3088,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3088,1,1,0)
 ;;=1^282.63
 ;;^UTILITY(U,$J,358.3,3088,1,8,0)
 ;;=8^Sickle-cell/Hb-C Dis w/o Crisis
 ;;^UTILITY(U,$J,358.3,3088,2)
 ;;=^330080
 ;;^UTILITY(U,$J,358.3,3089,0)
 ;;=282.64^^29^255^50
 ;;^UTILITY(U,$J,358.3,3089,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3089,1,1,0)
 ;;=1^282.64
 ;;^UTILITY(U,$J,358.3,3089,1,8,0)
 ;;=8^Sickle-cell/Hb-C Dis w/ Crisis
 ;;^UTILITY(U,$J,358.3,3089,2)
 ;;=^329911
 ;;^UTILITY(U,$J,358.3,3090,0)
 ;;=282.68^^29^255^38
 ;;^UTILITY(U,$J,358.3,3090,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3090,1,1,0)
 ;;=1^282.68
 ;;^UTILITY(U,$J,358.3,3090,1,8,0)
 ;;=8^Oth Sickle-cell Dis w/o Crisis
 ;;^UTILITY(U,$J,358.3,3090,2)
 ;;=^329912
 ;;^UTILITY(U,$J,358.3,3091,0)
 ;;=282.69^^29^255^37
 ;;^UTILITY(U,$J,358.3,3091,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3091,1,1,0)
 ;;=1^282.69
 ;;^UTILITY(U,$J,358.3,3091,1,8,0)
 ;;=8^Oth Sickle-cell Dis w/ Crisis
 ;;^UTILITY(U,$J,358.3,3091,2)
 ;;=^330081
 ;;^UTILITY(U,$J,358.3,3092,0)
 ;;=282.7^^29^255^34
 ;;^UTILITY(U,$J,358.3,3092,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3092,1,1,0)
 ;;=1^282.7
 ;;^UTILITY(U,$J,358.3,3092,1,8,0)
 ;;=8^Oth Hemoglobinopathies
 ;;^UTILITY(U,$J,358.3,3092,2)
 ;;=^87629
 ;;^UTILITY(U,$J,358.3,3093,0)
 ;;=282.8^^29^255^40
 ;;^UTILITY(U,$J,358.3,3093,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3093,1,1,0)
 ;;=1^282.8
 ;;^UTILITY(U,$J,358.3,3093,1,8,0)
 ;;=8^Oth Spec Hereditary Hemolytic
 ;;^UTILITY(U,$J,358.3,3093,2)
 ;;=^267984
 ;;^UTILITY(U,$J,358.3,3094,0)
 ;;=283.10^^29^255^31
 ;;^UTILITY(U,$J,358.3,3094,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3094,1,1,0)
 ;;=1^283.10
 ;;^UTILITY(U,$J,358.3,3094,1,8,0)
 ;;=8^Non-autoimmune Hemolytic Anemia
 ;;^UTILITY(U,$J,358.3,3094,2)
 ;;=^294004
 ;;^UTILITY(U,$J,358.3,3095,0)
 ;;=283.11^^29^255^22
 ;;^UTILITY(U,$J,358.3,3095,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,3095,1,1,0)
 ;;=1^283.11
 ;;^UTILITY(U,$J,358.3,3095,1,8,0)
 ;;=8^Hemolytic-uremic Syndrome
 ;;^UTILITY(U,$J,358.3,3095,2)
 ;;=^293663
 ;;^UTILITY(U,$J,358.3,3096,0)
 ;;=285.0^^29^255^52
